# The Effect of Curcumin on Inflammatory Markers in Hemodialysis Patients

> **NCT06829186** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Guadalajara** · enrollment: 70 (estimated)

## Conditions studied

- Hemodialysis

## Interventions

- **DIETARY_SUPPLEMENT:** Curcumin (Longvida™)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06829186
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-15
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06829186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06829186, "The Effect of Curcumin on Inflammatory Markers in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06829186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*